BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.95), EUR0.20 better than the analyst estimate of (EUR2.15). Revenue for the quarter came in at EUR118.1 million versus the consensus estimate of EUR185.6 million.

GUIDANCE:

BioNTech SE sees FY2026 revenue of EUR2-2.3 billion, versus the consensus of EUR2.185 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.